Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 58NETWORK 17NIH 16INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 109Leukemia 21Recurrence 12Myelodysplastic Syndromes 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms 5Leukemia, Myeloid 5Hematologic Neoplasms 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Lymphoma 3Leukemia, Biphenotypic, Acute 3Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Hematologic Diseases 2Congenital Abnormalities 2Thrombocytopenia 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Pathologic Complete Response 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloid Malignancies 1Meningitis 1Meningeal Neoplasms 1Lymphoma, Mantle-Cell 1

Interventions

tisagenlecleucel 8Cyclophosphamide 7fludarabine 5blinatumomab 5aflibercept 4ibrutinib 2epratuzumab 2Vincristine 2Radioimmunodetection 2Methotrexate 2MLN 8237 2Inotuzumab Ozogamicin 2Dexamethasone 2tocilizumab 1tafasitamab 1siltuximab 1sepantronium 1ruxolitinib 1relatlimab 1pembrolizumab 1pegaspargase 1ontuxizumab 1obinutuzumab 1loncastuximab tesirine 1forodesine 1fludarabine phosphate 1fiu protein, E coli 1exatecan 1brexucabtagene autoleucel 1asparaginase erwinia chrysanthemi recombinant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Burkitt Lymphoma × Cytarabine × Clear all
NCT02723994 2026-03-11

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Incyte Corporation

Phase 2 Completed
171 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡